Literature DB >> 8676493

cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations.

E Berthold1, F Maldarelli.   

Abstract

Two distinct intranuclear locations were identified for alternatively spliced RNA transcripts expressed from the pNL4-3 infectious molecular clone of human immunodeficiency virus (HIV) type 1. Multiply spliced HIV RNA encoding tat was detected within the nucleus in large clusters; immunostaining and colocalization studies using laser-scanning confocal microscopy revealed that these structures contained the non-small nuclear ribonucleoprotein RNA processing factor, SC35. In contrast, unspliced gag RNA was detected in much smaller granules distributed throughout the nucleus, with little or no association with SC35-containing granules. Analyses of nuclear RNA expressed from recombinant plasmids encoding gag (pCMVgag-2) alone or tat (pCMVtat-2) alone revealed distributions corresponding to those obtained with pNL4-3, indicating that expression within the context of the HIV provirus was not required for the distinct RNA locations detected for these transcripts. The presence of unspliced gag RNA in small granules was confirmed in infections of H9 T-lymphocytic cells, indicating that gag localization was not restricted to transient expression systems. The intranuclear distribution of gag RNA was dependent on specific RNA sequences. Deletion of a portion of the gag gene of pCMVgag-2, containing a cis-repressing inhibitory region, resulted in redirection of unspliced gag RNA from small granules into large SC35-containing clusters. The addition of the Rev-responsive element, RRE, to the deleted pCMVgag-2 construct resulted in RNA transcripts which were no longer associated with SC35. We also identified a cellular intron, rabbit beta-globin-intervening sequence 2 (IVS-2) which, when introduced into pCMVgag-2, redirected unspliced gag RNA into SC35-containing granules and permitted rev-independent Gag expression. These findings suggest that redirecting intranuclear RNA localization may influence gene expression. Color micrographs from this article are available for view at http//128.231.216.2/lmmhome.htm.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676493      PMCID: PMC190403     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Sequence and position requirements for uridylate-rich downstream elements of polyadenylation signals.

Authors:  Z F Chou; F Chen; J Wilusz
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

Review 2.  hnRNP proteins and the biogenesis of mRNA.

Authors:  G Dreyfuss; M J Matunis; S Piñol-Roma; C G Burd
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm.

Authors:  K H Kalland; A M Szilvay; E Langhoff; G Haukenes
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.

Authors:  G Nasioulas; A S Zolotukhin; C Tabernero; L Solomin; C P Cunningham; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

5.  A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.

Authors:  D A Mann; I Mikaélian; R W Zemmel; S M Green; A D Lowe; T Kimura; M Singh; P J Butler; M J Gait; J Karn
Journal:  J Mol Biol       Date:  1994-08-12       Impact factor: 5.469

6.  Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron.

Authors:  M L Hammarskjöld; H Li; D Rekosh; S Prasad
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.

Authors:  H Park; M V Davies; J O Langland; H W Chang; Y S Nam; J Tartaglia; E Paoletti; B L Jacobs; R J Kaufman; S Venkatesan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.

Authors:  D W Brighty; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors.

Authors:  R T O'Keefe; A Mayeda; C L Sadowski; A R Krainer; D L Spector
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

10.  In vivo analysis of the stability and transport of nuclear poly(A)+ RNA.

Authors:  S Huang; T J Deerinck; M H Ellisman; D L Spector
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more
  18 in total

1.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Implication of a cis-acting element in the cytoplasmic accumulation of unspliced Borna disease virus RNAs.

Authors:  P A Schneider; M Schwemmle; W I Lipkin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.

Authors:  M S McBride; M D Schwartz; A T Panganiban
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev-RRE interaction.

Authors:  Sumeer Raina; Ajit G Chande; Masanori Baba; Robin Mukhopadhyaya
Journal:  Virusdisease       Date:  2013-09-27

5.  Efficient expression by an alphavirus replicon of a functional ribozyme targeted to human immunodeficiency virus type 1.

Authors:  S M Smith; F Maldarelli; K T Jeang
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.

Authors:  P Bell; L J Montaner; G G Maul
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.

Authors:  Y Cui; T Iwakuma; L J Chang
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.

Authors:  Dusan Cmarko; Stig-Ove Bøe; Catia Scassellati; Anne Marie Szilvay; Svend Davanger; Xiang-Dong Fu; Gunnar Haukenes; Karl-Henning Kalland; Stanislav Fakan
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression.

Authors:  Andrei S Zolotukhin; Daniel Michalowski; Jenifer Bear; Sergey V Smulevitch; Abdulmaged M Traish; Rui Peng; James Patton; Ivan N Shatsky; Barbara K Felber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair.

Authors:  Rachel M Koldej; Donald S Anson
Journal:  BMC Biotechnol       Date:  2009-10-07       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.